亚洲 · 区域市场 · Business Standard
Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat
Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts.
在 Business Standard 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.business-standard.com)
